Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer “Revision” version has been incremented from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check10 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedNew page revision tag v3.5.0 was added. The previous revision tag v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a background version-label change that does not affect study details or user workflows.SummaryDifference0.1%

- Check75 days agoChange DetectedA new site revision label `Revision: v3.4.2` has been added. The previously displayed government funding status notice (lapse in funding) has been removed.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice regarding government funding and a revision update from v3.4.0 to v3.4.1 were added. No study content, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.